Loading clinical trials...
Loading clinical trials...
To Evaluate the Correlation Between Peripheral Neurofilament Levels and Clinical Subtypes of Amyotrophic Lateral Sclerosis and the Severity of Peripheral Motor Axonal Involvement.
To evaluate the correlation between peripheral neurofilament levels and clinical subtypes of amyotrophic lateral sclerosis and the severity of peripheral motor axonal involvement.
Amyotrophic lateral sclerosis (ALS) is a kind of neurodegenerative disease that affects upper and lower motor neurons. In animal model studies have shown that peripheral nerve degeneration in ALS motor function decline, tip peripheral nerve degeneration is of great significance for early progress of ALS may be, at the same time analysis showed that the motor neuron involvement severity and the prognosis of patients with ALS show obvious negative correlation, so finding biomarkers can reflect the motor neuron axonal degeneration is of great significance. Neurofilaments is an intermediate fiber specifically expressed in central and peripheral neurons and can serve as a biomarker for axonal injury, but there is no evidence now that peripheral neurofilament levels have been associated with severity of motor axonal involvement in ALS.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Peking University Third Hospital
Beijing, China
Start Date
August 1, 2017
Primary Completion Date
May 1, 2019
Completion Date
May 1, 2019
Last Updated
July 2, 2020
103
ACTUAL participants
LMND-ALS
OTHER
UMND-ALS
OTHER
FAS and FLS
OTHER
Lead Sponsor
Peking University Third Hospital
NCT07322003
NCT05104710
NCT07357428
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions